Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_assertion type Assertion NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_head.
- NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_assertion wasGeneratedBy ECO_0000218 NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_provenance.
- NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_assertion wasDerivedFrom ctd_human-20130708 NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_provenance.
- NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_assertion SIO_000772 17043644 NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_provenance.
- NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_assertion evidence source_evidence_curated NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_provenance.
- NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_assertion description "[Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP25235.RA5GgeIElGTfH61ldxjx7PAgV3E3zCo5fHUpp0_9L18go130_provenance.